NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024
NextCure, Inc. (NASDAQ:NXTC) and LigaChem Biosciences, Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 288,303 | $461,284 | +21% | 0.05% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 277,202 | $443,523 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 171,202 | $273,923 | +183% | 0% |
| 4. | Millennium Management Israel Englander | 88,112 | $140,979 | 0% | |
| 5. | Squadron Capital Management William Blank | 64,464 | $103,142 | -76% | 0.03% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 3,553 | $18,103.60 | 733,270 | 2026-10-27 | Filing | |
| $5.03 | 1,672 | $8,417.52 | 729,717 | 2026-10-26 | Filing | |
| $4.83 | 5,626 | $27,170.20 | 728,045 | 2026-10-23 | Filing | |
| $4.80 | 8,003 | $38,414.40 | 722,419 | 2026-07-31 | Filing | |
| $4.98 | 25,000 | $124,540.00 | 714,416 | 2026-07-31 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.16 | 30,000 | $184,800.00 | 308,636 | 2026-08-10 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,000 | $5,010 | 0% |